The Three COVID-19 Treatments: Vaccine, Antibody, And Inhibitor

Huixin Xie

doi:10.54097/7y0bdc26

Authors

Huixin Xie

DOI:

https://doi.org/10.54097/7y0bdc26

Keywords:

antibody, COVID-19, inhibitor, treatment, vaccine.

Abstract

Coronavirus disease (COVID-19) as a severe contagion induces the international public health emergency. Millions of people have been infected or died. The whole society affected because of the suspending of work. To deal with this situation, scientist did studies and research on various kinds of treatments. Among those, vaccine, antibody and inhibitor are three common treatments for COVID-19. Vaccines, by mimicking the infection of external pathogens but with lower pathogenicity, help the host establish long-term protection, which is the key prophylactic strategy. Antibody, the product of immune response, is taken as the treatment after infection. Inhibitor, usually small molecules or enzymatic analogues, aims to interfere with the functions of viral enzyme and disrupt the life cycle of virus. In this review, we conducted a thorough investigation by literature reviewing, illustrating the definition, components and mechanisms of these three treatments, besides, some specific approved drugs in the corresponding categories are also presented.

Downloads

Download data is not yet available.

References

[1] Shah, Jay Narayan, Jenifei Shah, and Jesifei Shah. Quarantine, Isolation and Lockdown: In Context of Covid-19. Journal of Patan Academy of Health Sciences.

[2] Cascella, Marco. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls, 2023.

[3] Machhi, Jatin, Jonathan Herskovitz, Ahmed M Senan, Debashis Dutta, Barnali Nath, Maxim D Oleynikov, Wilson R Blomberg, et al. The Natural History, Pathobiology, and Clinical Manifestations of SARS-COV-2 Infections. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology, 2020.

[4] Coronavirus Death Toll. Worldometer.

[5] Timofeeva, Anna M, Sergey E Sedykh, Tatyana A Sedykh, and Georgy A Nevinsky. Natural Antibodies Produced in Vaccinated Patients and Covid-19 Convalescents Recognize and Hydrolyze Oligopeptides Corresponding to the S-Protein of SARS-COV-2. Vaccines, 2023.

[6] Vaccines and Immunization: What Is Vaccination? World Health Organization.

[7] Explaining How Vaccines Work. Centers for Disease Control and Prevention, 2023.

[8] Vaccines. Johns Hopkins Medicine, 2024.

[9] Coon, Lisa. What Is a Booster Shot and Why Do I Need It?: OSF Healthcare. OSF HealthCare Blog, 2024.

[10] professional, Cleveland Clinic medical. Covid Vaccine. Cleveland Clinic, 2024.

[11] Vanaparthy, Rachana, Gisha Mohan, Deepa Vasireddy, and Paavani Atluri. Review of Covid-19 Viral Vector-Based Vaccines and Covid-19 Variants. Le infezioni in medicina, 2021.

[12] What’s Different about Messenger RNA (Mrna) Vaccines for COVID-19? Memorial Sloan Kettering Cancer Center.

[13] MRNA Vaccines for COVID-19. University of Utah Health | University of Utah Health, 2024.

[14] What Is an Antibody? Medical News Today.

[15] professional, Cleveland Clinic medical. Antibodies: Definition, Types & Function. Cleveland Clinic, 2024.

[16] Scourfield, D Oliver, Sophie G Reed, Max Quastel, Jennifer Alderson, Valentina M T Bart, Alicia Teijeira Crespo, Ruth Jones, Ellie Pring, Felix Clemens Richter, and Stephanie E A Burnell. The Role and Uses of Antibodies in COVID-19 Infections: A Living Review. OUP Academic, 2021.

[17] Covid-19: Which Monoclonal Antibodies Should Be Used for Vulnerable Individuals? Institut Pasteur, 2024.

[18] Small-Molecule Inhibitors (Inhibitors, Agonists and Modulators). BOC Sciences.

[19] Lei, Sibei, Xiaohua Chen, Jieping Wu, Xingmei Duan, and Ke Men. Small Molecules in the Treatment of COVID-19. Nature News, 2022.

[20] Yang, Liyan, and Zhonglei Wang. Bench-to-Bedside: Innovation of Small Molecule Anti-SARS-Cov-2 Drugs in China. European journal of medicinal chemistry, 2023.

[21] Richman, Douglas D. Covid-19 Vaccines: Implementation, Limitations and Opportunities. Global health & medicine, 2021.

[22] Nagoba, Basavraj, Ajay Gavkare, Nawab Jamadar, Sachin Mumbre, and Sohan Selkar. Positive Aspects, Negative Aspects and Limitations of Plasma Therapy with Special Reference to COVID-19. Journal of infection and public health, 2020.

[23] Hernandez, Adrian V, Alejandro Piscoya, Vinay Pasupuleti, Mi T Phan, Sreya Julakanti, Phirin Khen, Yuani M Roman, César O Carranza-Tamayo, Angel an Escobedo, and C Michael White. Beneficial and Harmful Effects of Monoclonal Antibodies for the Treatment and Prophylaxis of COVID-19: Systematic Review and Meta-Analysis. The American journal of medicine, 2022.

[24] Lei, Sibei, Xiaohua Chen, Jieping Wu, Xingmei Duan, and Ke Men. Small Molecules in the Treatment of COVID-19. Nature News, 2022.